展望2026年，该行估计公司收入将按年增长16%至约80亿元，净利润按年增长14%，净利润率按年收窄 1个百分点至15%。该行上调对泰格医药的2026至2027年收入预测1%至7%，但下调同期每股盈利预测 8%至12%，因调低毛利率并上调销售、行政开支及研发开支。该行维持对其"持有"评级，目标价由38 港元上调至45港元。 格隆汇3月3日｜大和发表研报指，泰格医药发盈喜，预期2025年收入按年增长1%至16%，至66.6亿至 76.8亿元，在2024年跌11%后重拾增长；预期净利润按年上升105%至204%，至8.3亿至12.3亿元；预期 经常性净利润按年下跌43%至61%，至3.3亿至4.9亿元，主要由于订单取消、订单单价下降以及团队扩 张相关营运成本增加。 ...

国泰海通晨报 2026 年 03 月 03 日 国泰海通证券股份有限公司 研究所 [汤蔚翔 Table_Authors] (分析师) 电话：021-38676172 邮箱：tangweixiang@gtht.com 登记编号：S0880511010007 [Table_Summary] 1、【策略研究】：热点主题交易热度节后回升，金属资源品主题普涨，AI 应用主题回调。中东战 火强化能源资源价格，Token 出海成为 AI 投资新叙事，重视两会内需方向增量政策。 2、【汽车研究】汽车：展望 2026 年，乘用车销量预计温和增长，新能源高端化趋势明确，细分 市场供给加速释放。我们看好全球化布局领先、高端化表现亮眼、智能化能力突出的车企。 3、【固定收益研究】：战争冲击对债券的影响往往呈现"短期避险—中期再定价"的阶段切换， 判断持续性需同时跟踪通胀/财政路径与尾部风险指标，而非仅看单一期限利率点位。 4、【食品饮料研究】海天味业：引领"餐饮解决方案"及"复调"商业模式并举将保障公司中长 期超额收益，同时我们预计新一轮提价潮即将到来，顺势而为有望实现"量价齐升"。 5、【海外科技研究】MINIMAX-WP：极致性 ...

重点关注 Q1 业绩预期、积极把握主题机会；手术机器人专题：政 策打通商业化瓶颈、千亿市场驶向发展快车道 医药生物 证券研究报告/行业定期报告 2026 年 03 月 02 日 -医药生物行业 3 月月报 | | | | | | 简称 | 股价 | | | EPS | | | | | PE | | | 评级 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 分析师：祝嘉琦 | | | （元） | 2023A | 2024A | 2025E | 2026E | 2027E | 2023A | 2024A | 2025E | 2026E | 2027E | | | 执业证书编号：S0740519040001 | | 药明生物 三生国健 | 40.22 | 0.82 | 0.81 | 0.96 | 1.17 | 1.47 | 48.95 | 49.59 | 42.00 | 34.37 | 27.42 | 买入 | | | | | 59.38 | 0.48 | 1.14 | 4 ...

经营范围含医学研究和试验发展（除人体干细胞、基因诊断与治疗技术开发和应用）；技术服务、技术 开发、技术咨询、技术交流、技术转让、技术推广；数据处理和存储支持服务；数据处理服务；翻译服 务；业务培训（不含教育培训、职业技能培训等需取得许可的培训）；人力资源服务（不含职业中介活 动、劳务派遣服务）；软件开发；软件销售；计算机系统服务；会议及展览服务（出国办展须经相关部 门审批）；非居住房地产租赁；租赁服务（不含许可类租赁服务）；园区管理服务；物业管理；市场营 销策划；企业管理咨询。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目： 职业中介活动。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部 门批准文件或许可证件为准） 企业名称成都泰格医药科技有限公司法定代表人余凌注册资本1000万人民币国标行业科学研究和技术服 务业>研究和试验发展>工程和技术研究和试验发展地址中国（四川）自由贸易试验区成都高新区天仁 路388号1栋4单元12层1201号附03、04号（自编号）企业类型有限责任公司（非自然人投资或控股的法 人独资）营业期限2026-2-28至无固定期限登记机关成都 ...

Core Insights - The report anticipates a fluctuating upward trend in the index, with a primary focus on style rebalancing [4][5] - The A-share market has shown signs of recovery after initial volatility, with significant performance differences among major indices [5][6] Domestic Policy and Market Liquidity - The People's Bank of China conducted a 600 billion MLF operation and net injected 300 billion, marking the 12th consecutive month of increased liquidity to ensure reasonable liquidity before and after the Spring Festival [2] - The strengthening of the RMB has stabilized expectations for cross-border capital flows [2] Sector Performance - In the technology sector, midstream high-end manufacturing has led the gains, particularly in defense, machinery, and power equipment, driven by geopolitical tensions and domestic equipment renewal cycles [2] - In the cyclical sector, building materials, steel, and coal have outperformed, with glass fiber leading due to supply-side optimization and demand from AI and new energy [3] - Conversely, the non-ferrous metals sector has seen a pullback due to fluctuating expectations around U.S. Federal Reserve interest rate cuts and geopolitical disturbances [3] Market Trends and Historical Context - Historical data from 2010 to 2025 indicates a high probability of the Shanghai Composite Index rising in the month following the Spring Festival, particularly after a month of adjustment or fluctuation [6] - The report suggests that the market is likely to follow a "diffusion" model of industry rotation rather than a dramatic style switch, with a focus on moderate rebalancing [6] Investment Strategy - The report recommends focusing on "supply constraints + visible profits" as dual main lines, particularly in midstream high-end manufacturing [6] - The core trading logic around the AI chain continues to revolve around profit visibility and supply shortages, with a cautious approach to market liquidity [6] - Opportunities for Chinese manufacturing to expand overseas are highlighted, particularly in sectors like power equipment and engineering machinery [6] Recommended Stocks - The March stock selection includes a mix of sectors such as central enterprise dividend ETFs, hospitality, electronics, military, machinery, beverages, and communications [10]

资讯日报：美伊日内瓦会谈取得进展 股票市场概览 港股市场表现 美股市场表现 2026 年 2 月 27 日 资讯日报 海外市场主要股市上日表现 | 指数 | 收盘价 | 日常跌 | 間微跌 | 年初至今 湖铁 | | --- | --- | --- | --- | --- | | | | (%) | (%) | | | | | | | (%) | | 恒生指数 | 26.381 | (1.44) | (0.12) | 2.93 | | 恒生科技 | 5.109 | (2.87) | (1.96) | (7.37) | | 恒生国企 | 8.814 | (2.44) | (1.62) | (1.12) | | 上证指数 | 4.147 | (0.01) | 1.58 | 4.48 | | 日经225 | 58.583 | 0.29 | 3.39 | 16.71 | | 新加坡海峡 | 5.008 | (0.87) | (1.06) | 0.00 | | 标普500 | 6.946 | (0.54) | (0.01) | 0.93 | | 纳斯达克 | 23.152 | (1.18) | (0.03) | (1. ...

Group 1 - The stock prices of BeiGene fell over 8%, WuXi Biologics dropped over 7%, and Tigermed and CR-CCM both declined over 5% [1] - Other companies such as Junshi Biosciences, WuXi AppTec, and Innovent Biologics also experienced declines in their stock prices [1]

2月26日，港股三大指数呈现高开低走行情，尾盘加速下跌。 截止收盘，恒生科技指数大跌2.87%，创去年7月以来新低，较去年10月高点回调超23%，恒生指数、国企指数分别下跌1.44%及2.44%。 | 名称 | 最新价 | 涨跌额 | 涨跌幅 ^ | | --- | --- | --- | --- | | 恒生科技指数 | 5109.33 | -151.17 | -2.87% | | 800700 | | | | | 国企指数 | 8814.29 | -220.46 | -2.44% | | 800100 | | | | | 恒生指数 | 26381.02 | -384.70 | -1.44% | | 800000 | | | | 具体盘面上，大型科技股、大金融股(银行、保险、券商)、中字头等权重集体下跌大市承压十分明显，汽车经销商股大跌，生物医药股、建材水泥股、濠赌 股、AI应用概念股、煤炭股、石油股、内房股、光伏股、黄金等有色金属股纷纷下跌。电力设备股逆市上扬，影视股部分反弹，存储概念股再度活跃。 | 行业热力图 × | 领域板块 | | | | | | | | | | --- | --- | --- | ...

港股创新药板块持续走弱，百济神州跌超8%，药明生物跌超7%，泰格医药、康龙化成、诺诚健华跟 跌。 ...

Core Insights - The report highlights changes in the Hong Kong Stock Connect holdings, indicating significant increases and decreases in ownership percentages for various companies. Group 1: Recent Increases in Holdings - VITASOY INT'L (00345) saw an increase of 0.09%, bringing its latest holding percentage to 3.75% [1] - 恒生科技ETF (03032) increased by 0.04%, with a current holding of 18.49% [1] - 永升服务 (01995) experienced a rise of 0.01%, now holding 4.57% [1] - 南方东西精选 (03441) had the largest increase over five days at 18.46%, reaching 41.03% [4] - 喜相逢集团 (02473) increased by 10.04%, with a holding of 45.14% [4] - 兆易创新 (03986) rose by 4.95%, now at 6.65% [4] Group 2: Recent Decreases in Holdings - 南方恒生科技 (03033) experienced the largest decrease of -0.14%, with a current holding of 68.87% [2] - 医渡科技 (02158) decreased by -0.03%, now at 22.59% [2] - 盈富基金 (02800) saw a reduction of -0.02%, with a holding of 3.49% [2] - 山东墨龙 (00568) had a five-day decrease of -1.30%, now at 53.56% [5] - 亿华通 (02402) decreased by -1.00%, with a holding of 27.49% [5] - 国富氢能 (02582) saw a reduction of -0.90%, now at 20.14% [5] Group 3: Long-term Trends in Holdings - Over a 20-day period, 喜相逢集团 (02473) had the highest increase of 42.45%, reaching 45.14% [6] - 南方东西精选 (03441) increased by 27.31%, now at 41.03% [6] - 钧达股份 (02865) rose by 15.74%, with a holding of 64.80% [6] - 天齐锂业 (09696) experienced a significant decrease of -6.48%, now at 31.50% [6] - 金风科技 (02208) decreased by -5.88%, with a holding of 42.49% [6]